These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16342006)
41. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. Trifirò G; Barbui C; Spina E; Moretti S; Tari M; Alacqua M; Caputi AP; ; Arcoraci V Pharmacoepidemiol Drug Saf; 2007 May; 16(5):552-9. PubMed ID: 16917790 [TBL] [Abstract][Full Text] [Related]
42. The effect of trimipramine on dream recall and dream emotions in depressive outpatients. Schredl M; Berger M; Riemann D Psychiatry Res; 2009 May; 167(3):279-86. PubMed ID: 19403177 [TBL] [Abstract][Full Text] [Related]
43. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
44. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078 [TBL] [Abstract][Full Text] [Related]
45. Combined trimipramine/phenelzine treatment of depression: case report. Lippmann S; Baldwin H; Manshadi M J Clin Psychiatry; 1982 Oct; 43(10):430-1. PubMed ID: 7118839 [TBL] [Abstract][Full Text] [Related]
46. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
47. [Surmontil in the treatment of depressive conditions]. Bogicević D Neuropsihijatrija; 1965; 13(1-4):159-62. PubMed ID: 16305133 [No Abstract] [Full Text] [Related]
48. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643 [TBL] [Abstract][Full Text] [Related]
49. Is it possible to be dependent to Tianeptine, an antidepressant? A case report. Kisa C; Bulbul DO; Aydemir C; Goka E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):776-8. PubMed ID: 17270334 [TBL] [Abstract][Full Text] [Related]
50. Superior safety of reboxetine over amitryptiline in the elderly. Agelink MW; Ullrich H; Passenberg P; Sayar K; Brockmeyer NH Eur J Med Res; 2002 Sep; 7(9):415-6. PubMed ID: 12435620 [TBL] [Abstract][Full Text] [Related]
51. [Eosinophilic pleuritis and hepatopathy under trimipramine therapy]. Hatzinger M; Stohler R; Holsboer-Trachsler E Schweiz Med Wochenschr; 1991 Jun; 121(24):910-2. PubMed ID: 1857950 [TBL] [Abstract][Full Text] [Related]
52. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
53. Postburn galactorrhea with refractory hypertrophic scars: role of obesity under scrutiny. Saraiya H J Burn Care Rehabil; 2003; 24(6):392-4. PubMed ID: 14610425 [TBL] [Abstract][Full Text] [Related]
54. Side effects of adjunct light therapy in patients with major depression. Müller MJ; Seifritz E; Hatzinger M; Hemmeter U; Holsboer-Trachsler E Eur Arch Psychiatry Clin Neurosci; 1997; 247(5):252-8. PubMed ID: 9444494 [TBL] [Abstract][Full Text] [Related]